Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
J Affect Disord. 2023 Jun 1;330:48-56. doi: 10.1016/j.jad.2023.02.108. Epub 2023 Feb 24.
Although many studies reported the neuropsychiatric involvement of testosterone (T) levels in the development of mood disorders, its role in this disabling disorder is still not well understood. Therefore, in this review, we aim to summarize the current literature exploring serum testosterone levels in both major depressive disorder (MDD) and bipolar disorder (BD), with particular attention given to the possible causal relationship between pathological mood alterations and T levels.
We selected 9 original studies from a bibliographic search on PubMed, excluding studies on hormonal therapy and other psychiatric disorders other than mood disorders.
The results reported by the reviewed studies were conflicting especially with regards to the presence of dysfunctional levels of T in patients with BD. Specifically, while MDD was found to be associated with low levels of T compared to healthy controls (HC), in BD the results were highly heterogeneous, with a mixed picture of reduced, increased or no difference in T levels in BD patients compared to HC.
Studies were highly heterogeneous in terms of samples employed, psychometric scales used for assessing depressive symptoms, T assay methods and therapeutic regimens.
Overall, T levels were shown to be reduced in both MDD and BD patients, ultimately suggesting that T could be useful as a biomarker in mood disorders and provide guidance for future research.
尽管许多研究报告了睾丸激素(T)水平与心境障碍发展之间的神经精神关联性,但它在这种致残性疾病中的作用仍未得到很好的理解。因此,在本次综述中,我们旨在总结目前关于重度抑郁症(MDD)和双相情感障碍(BD)患者血清睾丸酮水平的文献,特别关注病理性情绪改变与 T 水平之间可能存在的因果关系。
我们在 PubMed 上进行文献检索,选择了 9 项原始研究,排除了关于激素治疗和心境障碍以外的其他精神障碍的研究。
综述研究报告的结果存在冲突,尤其是在 BD 患者中 T 水平功能失调的存在方面。具体而言,与健康对照组(HC)相比,MDD 患者的 T 水平较低,但在 BD 中,结果高度异质,BD 患者与 HC 相比,T 水平降低、升高或无差异的情况均有。
研究在样本、评估抑郁症状的心理计量量表、T 检测方法和治疗方案方面存在高度异质性。
总体而言,MDD 和 BD 患者的 T 水平均降低,最终表明 T 可作为心境障碍的生物标志物,为未来的研究提供指导。